Your browser doesn't support javascript.
loading
Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years.
Lopez Bernal, Jamie; Andrews, Nick; Gower, Charlotte; Stowe, Julia; Tessier, Elise; Simmons, Ruth; Ramsay, Mary.
Afiliación
  • Lopez Bernal J; Public Health England, London, United Kingdom.
  • Andrews N; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Gower C; NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, United Kingdom.
  • Stowe J; Public Health England, London, United Kingdom.
  • Tessier E; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Simmons R; Public Health England, London, United Kingdom.
  • Ramsay M; Public Health England, London, United Kingdom.
Clin Infect Dis ; 78(2): 349-351, 2024 02 17.
Article en En | MEDLINE | ID: mdl-37758203
We estimated the risk of death from coronavirus disease 2019 in vaccinated compared with unvaccinated patients. The risk of death was reduced 44% after 1 dose of the Pfizer-BioNTech BNT162b2 vaccine, 55% after 1 dose of the Oxford-Astrazeneca ChAdOx1 vaccine, and 69% after 2 doses of the BNT162b2 vaccine. This is above the protection provided against infection.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Vacunas contra el Adenovirus / COVID-19 Límite: Adult / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Vacunas contra el Adenovirus / COVID-19 Límite: Adult / Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido